← Leaderboards
Anjana Rao
Immune Disease Institute, Inc.
$82,017,396
Attributed
$106,303,005
Total exposure
33
Grants
25
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $16.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$106,303,005 · 33
By mechanism
R01$62,958,003 · 14
RC4$12,579,073 · 1
R35$9,486,061 · 1
U01$5,910,517 · 2
R24$4,208,257 · 1
R37$3,567,839 · 1
Top collaborators
- Patrick Hogan24 shared
- Bjoern Peters9 shared
- Pandurangan Vijayanand9 shared
- J. Silvio Gutkind6 shared
- Stephen Philip Schoenberger6 shared
- Mitchell Kronenberg5 shared
Most similar at Immune Disease Institute, Inc.
Same institution · by research overlap
- Klaus Rajewsky$14,880,877
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTranscription FactorT-LymphocyteProteinsGenesMalignant NeoplasmsImmuneMolecularResponseGene ExpressionCytokineSignal TransductionFamilyBaseImmune SystemMutationGenome-WideAntigensPaperCell TypePathway InteractionsCell PhysiologyLaboratoriesMouse Model
Grant awards (173)
Signal transduction and gene induction in lymphocytes$1,976,400
R01 · FY2025 · AI
The TET-DNMT-ASXL1-OGT axis: relevance to clonal hematopoiesis, heterochromatin integrity and cancer$1,098,000
R35 · FY2025 · CA · contact PI
Investigating the role of TET deficiency in promoting T cell expansion and inflammation$1,098,000
R01 · FY2025 · AI · contact PI
Dysregulation of TET dioxygenase function as a source of aberrant transposable element expression during human aging$639,037
U01 · FY2025 · AI · contact PI
The TET-DNMT-ASXL1-OGT axis: relevance to clonal hematopoiesis, heterochromatin integrity and cancer$1,098,000
R35 · FY2024 · CA · contact PI
NFAT, bZIP proteins, and transcriptional programs in lymphocytes$842,353
R01 · FY2024 · AI
Signal transduction and gene induction in lymphocytes$658,800
R01 · FY2024 · AI
Dysregulation of TET dioxygenase function as a source of aberrant transposable element expression during human aging$658,800
U01 · FY2024 · AI · contact PI
Investigating the role of TET deficiency in promoting T cell expansion and inflammation$549,000
R01 · FY2024 · AI · contact PI
Exploring the potential of TET inhibition in cancer immunotherapy$477,498
R01 · FY2024 · CA · contact PI
Investigating the role of TET deficiency in promoting T cell expansion and inflammation$130,237
R01 · FY2024 · AI · contact PI
Exploring the potential of TET inhibition in cancer immunotherapy$99,352
R01 · FY2024 · CA · contact PI
NFAT, bZIP proteins, and transcriptional programs in lymphocytes$842,353
R01 · FY2023 · AI
Signal transduction and gene induction in lymphocytes$658,800
R01 · FY2023 · AI
Investigating the role of TET deficiency in promoting T cell expansion and inflammation$549,000
R01 · FY2023 · AI · contact PI
Exploring the potential of TET inhibition in cancer immunotherapy$492,576
R01 · FY2023 · CA · contact PI
Exploring the potential of TET inhibition in cancer immunotherapy$104,582
R01 · FY2023 · CA · contact PI
TET enzymes as guardians of genome stability$1,058,400
R35 · FY2022 · CA · contact PI
NFAT, bZIP proteins, and transcriptional programs in lymphocytes$842,353
R01 · FY2022 · AI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers$838,091
U01 · FY2022 · DE
Investigating the role of TET deficiency in promoting T cell expansion and inflammation$549,000
R01 · FY2022 · AI · contact PI
Signal transduction and gene induction in lymphocytes$540,000
R01 · FY2022 · AI · contact PI
Exploring the potential of TET inhibition in cancer immunotherapy$492,576
R01 · FY2022 · CA · contact PI
TET enzymes as guardians of genome stability$1,080,000
R35 · FY2021 · CA · contact PI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers$849,319
U01 · FY2021 · DE
NFAT, bZIP proteins, and transcriptional programs in lymphocytes$842,353
R01 · FY2021 · AI
Signal transduction and gene induction in lymphocytes$540,000
R01 · FY2021 · AI · contact PI
Exploring the potential of TET inhibition in cancer immunotherapy$502,630
R01 · FY2021 · CA · contact PI
Epigenetic control of Foxp3 expression in induced T regulatory cells$450,000
R01 · FY2021 · AI · contact PI
TET enzymes as guardians of genome stability$1,080,000
R35 · FY2020 · CA · contact PI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers$827,143
U01 · FY2020 · DE
NFAT, bZIP proteins, and transcriptional programs in lymphocytes$669,740
R01 · FY2020 · AI
Signal transduction and gene induction in lymphocytes$540,000
R01 · FY2020 · AI · contact PI
Exploring the potential of TET inhibition in cancer immunotherapy$502,630
R01 · FY2020 · CA · contact PI
Epigenetic control of Foxp3 expression in induced T regulatory cells$450,000
R01 · FY2020 · AI · contact PI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers$366,000
U01 · FY2020 · DE
TET enzymes as guardians of genome stability$1,047,600
R35 · FY2019 · CA · contact PI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers$852,739
U01 · FY2019 · DE
Signal transduction and gene induction in lymphocytes$540,000
R01 · FY2019 · AI · contact PI
Epigenetic control of Foxp3 expression in induced T regulatory cells$450,000
R01 · FY2019 · AI · contact PI
NFAT, bZIP proteins, and transcriptional programs in lymphocytes$414,272
R56 · FY2019 · AI
TET enzymes as guardians of genome stability$1,080,000
R35 · FY2018 · CA · contact PI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers$879,388
U01 · FY2018 · DE
bZIP proteins, NFAT, and lymphocyte gene induction$732,684
R01 · FY2018 · AI · contact PI
Epigenetic control of Foxp3 expression in induced T regulatory cells$630,000
R01 · FY2018 · AI · contact PI
Signal transduction and gene induction in lymphocytes$540,000
R01 · FY2018 · AI · contact PI
TET enzymes as guardians of genome stability$1,080,000
R35 · FY2017 · CA · contact PI
Research Resources: Epigenomic and Transcriptomic Profiles of Human Immune Cells$899,177
R24 · FY2017 · AI · contact PI
bZIP proteins, NFAT, and lymphocyte gene induction$732,684
R01 · FY2017 · AI · contact PI
Epigenetic control of Foxp3 expression in induced T regulatory cells$450,000
R01 · FY2017 · AI · contact PI
Research Resources: Epigenomic and Transcriptomic Profiles of Human Immune Cells$1,204,371
R24 · FY2016 · AI · contact PI
TET enzymes as guardians of genome stability$864,061
R35 · FY2016 · CA · contact PI
bZIP proteins, NFAT, and lymphocyte gene induction$732,684
R01 · FY2016 · AI · contact PI
Signal transduction and gene induction in lymphocytes$435,000
R01 · FY2016 · AI · contact PI
Role of TET proteins in myeloid malignancies$370,180
R01 · FY2016 · CA · contact PI
Molecular signatures in allergy and asthma$337,338
U19 · FY2016 · AI · contact PI
Research Resources: Epigenomic and Transcriptomic Profiles of Human Immune Cells$1,205,532
R24 · FY2015 · AI · contact PI
Epigenomics of T cells and innate immune cells in human asthma$1,097,910
R01 · FY2015 · HL · contact PI
bZIP proteins, NFAT, and lymphocyte gene induction$732,684
R01 · FY2015 · AI · contact PI
Signal transduction and gene induction in lymphocytes$435,000
R01 · FY2015 · AI · contact PI
Role of TET proteins in myeloid malignancies$370,180
R01 · FY2015 · CA · contact PI
Role of TET Proteins in ES Cell Pluripotency and Function$347,880
R01 · FY2015 · HD · contact PI
Molecular signatures in allergy and asthma$330,071
U19 · FY2015 · AI · contact PI
Epigenomics of T cells and innate immune cells in human asthma$1,092,337
R01 · FY2014 · HL · contact PI
Research Resources: Epigenomic and Transcriptomic Profiles of Human Immune Cells$899,177
R24 · FY2014 · AI · contact PI
bZIP proteins, NFAT, and lymphocyte gene induction$678,945
R01 · FY2014 · AI · contact PI
Regulated Accessibility of a cytokine gene locus.$645,587
R01 · FY2014 · AI · contact PI
Signal transduction and gene induction in lymphocytes$435,000
R01 · FY2014 · AI · contact PI
Role of TET proteins in myeloid malignancies$387,133
R01 · FY2014 · CA · contact PI
Role of TET Proteins in ES Cell Pluripotency and Function$346,811
R01 · FY2014 · HD · contact PI
Molecular signatures in allergy and asthma$320,970
U19 · FY2014 · AI · contact PI
Epigenomics of T cells and innate immune cells in human asthma$1,061,129
R01 · FY2013 · HL · contact PI
Regulated Accessibility of a cytokine gene locus.$718,361
R01 · FY2013 · AI · contact PI
Illumina HiSeq 2500 Sequencing System$600,000
S10 · FY2013 · OD · contact PI
Regulation of store-operated Ca2+ entry: STIM and ORAI$514,796
R01 · FY2013 · AI · contact PI
Regulation of CD45 alternative splicing by HNRPLL$410,898
R01 · FY2013 · AI · contact PI
Signal transduction and gene induction in lymphocytes$408,900
R01 · FY2013 · AI · contact PI
Role of TET proteins in myeloid malignancies$347,969
R01 · FY2013 · CA · contact PI
Role of TET Proteins in ES Cell Pluripotency and Function$338,603
R01 · FY2013 · HD · contact PI
Molecular signatures in allergy and asthma$307,321
U19 · FY2013 · AI · contact PI
Epigenomics of T cells and innate immune cells in human asthma$1,114,630
R01 · FY2012 · HL · contact PI
Regulated Accessibility of a cytokine gene locus.$645,587
R01 · FY2012 · AI · contact PI
BZIP PROTEINS AND LYMPHOCYTE GENE INDUCTION$581,130
R01 · FY2012 · CA · contact PI
Regulation of store-operated Ca2+ entry: STIM and ORAI$547,654
R01 · FY2012 · AI · contact PI
Regulation of CD45 alternative splicing by HNRPLL$437,125
R01 · FY2012 · AI · contact PI
Signal transduction and gene induction in lymphocytes$435,000
R01 · FY2012 · AI · contact PI
Role of TET proteins in myeloid malignancies$370,180
R01 · FY2012 · CA · contact PI
Role of TET Proteins in ES Cell Pluripotency and Function$356,800
R01 · FY2012 · HD · contact PI
Molecular signatures in allergy and asthma$340,554
U19 · FY2012 · AI · contact PI
Epigenomics of T cells and innate immune cells in human asthma$1,126,630
R01 · FY2011 · HL · contact PI
Regulated Accessibility of a cytokine gene locus.$647,238
R01 · FY2011 · AI · contact PI
BZIP PROTEINS AND LYMPHOCYTE GENE INDUCTION$582,965
R01 · FY2011 · CA · contact PI
Regulation of store-operated Ca2+ entry: STIM and ORAI$547,871
R01 · FY2011 · AI · contact PI
Role of micro-RNAs in T cells and other immune/haematopoietic cells$424,401
R01 · FY2011 · AI · contact PI
Regulation of CD45 alternative splicing by HNRPLL$398,633
R01 · FY2011 · AI · contact PI
Role of TET Proteins in ES Cell Pluripotency and Function$236,719
R01 · FY2011 · HD · contact PI
Role of TET Proteins in ES Cell Pluripotency and Function$141,351
R01 · FY2011 · HD · contact PI
STRUCTURAL BASIS OF CA2+-CALMODULIN-CALCINEURIN SIGNALLING$1,845
P41 · FY2011 · RR · contact PI
New players in immune function: identification through RNAi and micro-RNA screens$12,579,073
RC4 · FY2010 · AI
Regulated Accessibility of a cytokine gene locus.$654,712
R01 · FY2010 · AI · contact PI
BZIP PROTEINS AND LYMPHOCYTE GENE INDUCTION$602,945
R01 · FY2010 · CA · contact PI
Regulation of store-operated Ca2+ entry: STIM and ORAI$554,745
R01 · FY2010 · AI · contact PI
Signal transduction and gene induction in T lymphocytes$551,078
R01 · FY2010 · AI · contact PI
Regulation of CD45 alternative splicing by HNRPLL$519,750
R01 · FY2010 · AI · contact PI
Chemical modulators of Tet-family proteins$500,000
RC1 · FY2010 · DA · contact PI
Role of micro-RNAs in T cells and other immune/haematopoietic cells$441,407
R01 · FY2010 · AI · contact PI
BZIP PROTEINS AND LYMPHOCYTE GENE INDUCTION$685,081
R01 · FY2009 · CA · contact PI
Transcriptional mechanisms underlying tolerance$659,198
R01 · FY2009 · AI · contact PI
Regulation of store-operated Ca2+ entry: STIM and ORAI$550,725
R01 · FY2009 · AI · contact PI
Signal transduction and gene induction in T lymphocytes$541,871
R01 · FY2009 · AI · contact PI
Regulation of CD45 alternative splicing by HNRPLL$525,000
R01 · FY2009 · AI · contact PI
Role of micro-RNAs in T cells and other immune/haematopoietic cells$515,025
R01 · FY2009 · AI · contact PI
Chemical modulators of Tet-family proteins$500,000
RC1 · FY2009 · DA · contact PI
STRUCTURAL BASIS OF CA2+-CALMODULIN-CALCINEURIN SIGNALLING$1,337
P41 · FY2009 · RR · contact PI
BZIP PROTEINS AND LYMPHOCYTE GENE INDUCTION$601,932
R01 · FY2008 · CA · contact PI
Transcriptional mechanisms underlying tolerance$576,097
R01 · FY2008 · AI · contact PI
Regulated Accessibility of a Cytokine Gene Locus$545,883
R01 · FY2008 · AI · contact PI
Signal transduction and gene induction in T lymphocytes$475,782
R01 · FY2008 · AI · contact PI
Role of micro-RNAs in T cells and other immune/haematopoietic cells$464,504
R01 · FY2008 · AI · contact PI
Regulators of Ca+ NFAT signaling a global RNAi screen$418,920
R01 · FY2008 · GM · contact PI
Transcriptional mechanisms underlying tolerance$570,362
R01 · FY2007 · AI · contact PI
Regulated Accessibility of a Cytokine Gene Locus$540,247
R01 · FY2007 · AI · contact PI
Role of micro-RNAs in T cells and other immune/haematopoietic cells$473,500
R01 · FY2007 · AI · contact PI
Signal transduction and gene induction in T lymphocytes$472,197
R01 · FY2007 · AI · contact PI
Regulators of Ca+ NFAT signaling a global RNAi screen$416,658
R01 · FY2007 · GM · contact PI
Crosstalk between Ca2+ signaling and the cytoskeleton$401,938
P01 · FY2007 · HL · contact PI
BZIP PROTEINS AND LYMPHOCYTE GENE INDUCTION$583,164
R37 · FY2006 · CA · contact PI
Transcriptional mechanisms underlying tolerance$570,287
R01 · FY2006 · AI · contact PI
Regulated Accessibility of a Cytokine Gene Locus$540,175
R01 · FY2006 · AI · contact PI
Signal transduction and gene induction in T lymphocytes$473,500
R01 · FY2006 · AI · contact PI
Regulators of Ca+ NFAT siginaling a global RNAi screen$426,838
R01 · FY2006 · GM · contact PI
Crosstalk between Ca2+ signaling and the cytoskeleton$399,149
P01 · FY2006 · HL · contact PI
CELL CYCLE AND APOPTOSIS REGULATION BY NFAT$33,748
R03 · FY2006 · TW · contact PI
BZIP PROTEINS AND LYMPHOCYTE GENE INDUCTION$579,805
R37 · FY2005 · CA
Regulated Accessibility of a Cytokine Gene Locus$537,062
R01 · FY2005 · AI
Molecular regulation of cytokine gene expression$498,891
P50 · FY2005 · HL
SIGNAL TRANSDUCTION AND GENE INDUCTION IN T LYMPHOCYTES$473,000
R01 · FY2005 · AI
Transcriptional mechanisms underlying tolerance$454,742
R01 · FY2005 · AI
Regulators of Ca+ NFAT signaling a global RNAi screen$434,860
R01 · FY2005 · GM
Crosstalk between Ca2+ signaling and the cytoskeleton$399,149
P01 · FY2005 · HL
Manipulation of T cell tolerance with small organic mol*$283,500
R21 · FY2005 · AI
CELL CYCLE AND APOPTOSIS REGULATION BY NFAT$34,560
R03 · FY2005 · TW
BZIP PROTEINS AND LYMPHOCYTE GENE INDUCTION$562,918
R37 · FY2004 · CA
Regulated Accessibility of a Cytokine Gene Locus$514,828
R01 · FY2004 · AI
SIGNAL TRANSDUCTION AND GENE INDUCTION IN T LYMPHOCYTES$473,000
R01 · FY2004 · AI
TRANSCRIPTIONAL MECHANISMS UNDERLYING TOLERANCE$468,540
R01 · FY2004 · AI
Crosstalk between Ca2+ signaling and the cytoskeleton$399,149
P01 · FY2004 · HL
Manipulation of T cell tolerance with small organic mol*$283,500
R21 · FY2004 · AI
CELL CYCLE AND APOPTOSIS REGULATION BY NFAT$34,560
R03 · FY2004 · TW
BZIP PROTEINS AND LYMPHOCYTE GENE INDUCTION$477,535
R37 · FY2003 · CA
TRANSCRIPTIONAL MECHANISMS UNDERLYING TOLERANCE$468,540
R01 · FY2003 · AI
REGULATED ACCESSIBILITY OF A CYTOKINE GENE LOCUS$444,327
R01 · FY2003 · AI
SIGNAL TRANSDUCTION AND GENE INDUCTION IN T LYMPHOCYTES$425,700
R01 · FY2003 · AI
Crosstalk between Ca2+ signaling and the cytoskeleton$399,149
P01 · FY2003 · HL
Molecular regulation of cytokine gene expression$487,054
P50 · FY2002 · HL
TRANSCRIPTIONAL MECHANISMS UNDERLYING TOLERANCE$468,540
R01 · FY2002 · AI
BZIP PROTEINS AND LYMPHOCYTE GENE INDUCTION$465,947
R37 · FY2002 · CA
REGULATED ACCESSIBILITY OF A CYTOKINE GENE LOCUS$432,719
R01 · FY2002 · AI
SIGNAL TRANSDUCTION AND GENE INDUCTION IN T LYMPHOCYTES$425,700
R01 · FY2002 · AI
CAPACITATIVE CALCIUM ENTRY DEFECT IN IMMUNE DEFICIENCY$94,600
R03 · FY2002 · HD
FUNCTION OF IKAPPA B IN LYMPHOCYTE AND NEURONS$32,000
R03 · FY2002 · TW
TRANSCRIPTIONAL MECHANISMS UNDERLYING TOLERANCE$462,296
R01 · FY2001 · AI
BZIP PROTEINS AND LYMPHOCYTE GENE INDUCTION$454,697
R37 · FY2001 · CA
SIGNAL TRANSDUCTION AND GENE INDUCTION IN T LYMPHOCYTES$450,700
R01 · FY2001 · AI
REGULATED ACCESSIBILITY OF A CYTOKINE GENE LOCUS$420,117
R01 · FY2001 · AI
CAPACITATIVE CALCIUM ENTRY DEFECT IN IMMUNE DEFICIENCY$94,600
R03 · FY2001 · HD
FUNCTION OF IKAPPA B IN LYMPHOCYTE AND NEURONS$32,000
R03 · FY2001 · TW
Molecular regulation of cytokine gene expression$0
P01 · FY2001 · HL
TRANSCRIPTIONAL MECHANISMS UNDERLYING TOLERANCE$462,296
R01 · FY2000 · AI
BZIP PROTEINS AND LYMPHOCYTE GENE INDUCTION$443,773
R37 · FY2000 · CA
REGULATED ACCESSIBILITY OF A CYTOKINE GENE LOCUS$407,881
R01 · FY2000 · AI
SIGNAL TRANSDUCTION AND GENE INDUCTION IN T LYMPHOCYTES$387,234
R01 · FY2000 · AI
FUNCTION OF IKAPPA B IN LYMPHOCYTE AND NEURONS$32,000
R03 · FY2000 · TW